IRCT20210519051345N21招募中未知
In vivo bioequivalence study of Quetiapine 25 mg tablet manufactured by Hakim Co. compared with innovator product
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
Bioequivalence study of Quetiapine 25 mg tabletIRCT20210519051345N50Tabriz University of Medical Sciences24
尚未招募
不适用
Bioequivalence study of Quetiapine 100 mg tabletIn the present study, no diseases will be examined and products will be administered by healthy volunteers..IRCT20210519051345N5Tabriz University of Medical Sciences24
已完成
4 期
Role of Quetiapine and Clozapine in Treatment Resistant Schizophrenia (TRS)CTRI/2016/02/006660Mitesh Kumar40
已完成
4 期
Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.HealthyNCT03317236Laboratorio Elea Phoenix S.A.24
已完成
1 期
Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting ConditionBioequivalenceNCT05235230Future University in Egypt32